QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)

Stryker - SYK Price Target & Analyst Ratings

$253.81
+4.27 (+1.71%)
(As of 01/31/2023 05:19 PM ET)
Add
Compare
Today's Range
$248.96
$253.96
50-Day Range
$224.65
$263.81
52-Week Range
$188.84
$279.28
Volume
1.73 million shs
Average Volume
1.36 million shs
Market Capitalization
$96.05 billion
P/E Ratio
39.47
Dividend Yield
1.18%
Price Target
$259.33

Stryker Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 18 Analyst Ratings

Consensus Analyst Price Target

$259.33
2.18% Upside
High Prediction$295.00
Average Prediction$259.33
Low Prediction$205.00
TypeCurrent
1/31/22 to 1/31/23
1 Month Ago
1/1/22 to 1/1/23
3 Months Ago
11/2/21 to 11/2/22
1 Year Ago
1/31/21 to 1/31/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
11 Buy rating(s)
11 Buy rating(s)
13 Buy rating(s)
14 Buy rating(s)
Hold
7 Hold rating(s)
7 Hold rating(s)
6 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$259.33$256.84$247.21$290.50
Predicted Upside2.18% Upside13.01% Upside11.75% Upside11.65% Upside
Get Stryker Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter.


SYK Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SYK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Stryker Stock vs. The Competition

TypeStrykerMedical CompaniesS&P 500
Consensus Rating Score
2.61
2.64
2.46
Consensus RatingModerate BuyBuyHold
Predicted Upside3.66% Upside949.21% Upside10.49% Upside
News Sentiment RatingNeutral News
Positive News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/25/2023KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageSector Weight ➝ Sector Weight
1/9/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSector Perform ➝ Outperform$240.00 ➝ $284.00+10.83%
1/6/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight$220.00 ➝ $260.00+2.97%
1/4/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$257.00 ➝ $265.00+7.71%
1/3/2023Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$265.00+7.62%
12/21/2022BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$232.00 ➝ $268.00+10.84%
12/20/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold$230.00 ➝ $252.00+5.54%
12/14/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$233.00 ➝ $283.00+11.44%
12/12/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$248.00 ➝ $281.00+13.40%
12/12/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$249.00 ➝ $282.00+15.28%
11/1/2022Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kyle Rose
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$225.00 ➝ $220.00-4.03%
10/12/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$270.00+27.68%
10/10/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$260.00 ➝ $250.00+19.89%
7/28/2022Edward Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
7/27/2022Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$297.00 ➝ $240.00+17.41%
7/21/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$285.00 ➝ $205.00+3.51%
7/18/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$285.00 ➝ $245.00+25.80%
7/11/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
3/16/2022Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$288.00 ➝ $295.00+15.99%
1/28/2022SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Antalffy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform$300.00 ➝ $285.00+16.17%
12/6/2021Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$305.00+19.89%
9/14/2021Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform
7/29/2021Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$280.00 ➝ $320.00+19.10%
7/28/2021Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Matt Miksic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform$291.00 ➝ $311.00+15.89%
7/28/2021Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform$273.00 ➝ $288.00+7.32%
7/28/2021Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$248.00 ➝ $310.00+15.52%
7/28/2021Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingHold
2/24/2021JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$245.00 ➝ $265.00+7.48%
1/4/2021Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral
10/30/2020Smith Barney Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$232.00 ➝ $240.00+20.29%
9/11/2020Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform$230.00+13.99%
7/31/2020UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$202.00 ➝ $215.00+12.77%
5/1/2020Cfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetStrong-Buy$234.00 ➝ $231.00+28.18%
4/1/2020The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Sell$248.00 ➝ $150.00-9.90%
(Data available from 1/31/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












SYK Price Target - Frequently Asked Questions

What is Stryker's consensus rating and price target?

According to the issued ratings of 18 analysts in the last year, the consensus rating for Stryker stock is Moderate Buy based on the current 7 hold ratings and 11 buy ratings for SYK. The average twelve-month price prediction for Stryker is $259.33 with a high price target of $295.00 and a low price target of $205.00. Learn more on SYK's analyst rating history.

Do Wall Street analysts like Stryker more than its competitors?

Analysts like Stryker less than other Medical companies. The consensus rating for Stryker is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how SYK compares to other companies.

Is Stryker being upgraded by Wall Street analysts?

Over the previous 90 days, Stryker's stock had 1 upgrade by analysts.

Does Stryker's stock price have much upside?

According to analysts, Stryker's stock has a predicted upside of 11.92% based on their 12-month price targets.

What analysts cover Stryker?

Stock Ratings Reports and Tools

This page (NYSE:SYK) was last updated on 1/31/2023 by MarketBeat.com Staff